NO20085282L - Humanized anti-human osteopontin antibody - Google Patents

Humanized anti-human osteopontin antibody

Info

Publication number
NO20085282L
NO20085282L NO20085282A NO20085282A NO20085282L NO 20085282 L NO20085282 L NO 20085282L NO 20085282 A NO20085282 A NO 20085282A NO 20085282 A NO20085282 A NO 20085282A NO 20085282 L NO20085282 L NO 20085282L
Authority
NO
Norway
Prior art keywords
human osteopontin
humanized anti
osteopontin antibody
antibody
human
Prior art date
Application number
NO20085282A
Other languages
English (en)
Inventor
Nobuchika Yamamoto
Fumihiko Sakai
Hirofumi Higuchi
Masaharu Torikai
Toshihior Nakashima
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Publication of NO20085282L publication Critical patent/NO20085282L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer et humanisert antihumant osteopontin-antistoff som har bedre aktiviteter (antigenbindingsaktivitet, levkocyttmigrasjonsinhiberende effekt og lignende) og/eller stabilitet (motsandsdyktighet overfor varme, lave pH-betingelser, denaturereingsmidler og lignende) enn de konvensjonelle antihumane osteopontin-antistoffene.
NO20085282A 2006-05-31 2008-12-18 Humanized anti-human osteopontin antibody NO20085282L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006152892 2006-05-31
PCT/JP2007/061026 WO2007139164A1 (ja) 2006-05-31 2007-05-30 ヒト化抗ヒトオステオポンチン抗体

Publications (1)

Publication Number Publication Date
NO20085282L true NO20085282L (no) 2009-02-26

Family

ID=38778682

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085282A NO20085282L (no) 2006-05-31 2008-12-18 Humanized anti-human osteopontin antibody

Country Status (17)

Country Link
US (1) US7807161B2 (no)
EP (1) EP2025749B8 (no)
JP (1) JP4064441B2 (no)
KR (1) KR20090024748A (no)
CN (1) CN101495632B (no)
AT (1) ATE553130T1 (no)
AU (1) AU2007268591A1 (no)
BR (1) BRPI0711229A2 (no)
CA (1) CA2653661A1 (no)
ES (1) ES2384350T3 (no)
IL (1) IL195503A0 (no)
MX (1) MX2008015309A (no)
NO (1) NO20085282L (no)
RU (1) RU2429016C2 (no)
TW (1) TW200813087A (no)
WO (1) WO2007139164A1 (no)
ZA (1) ZA200810863B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5440179B2 (ja) 2008-01-11 2014-03-12 アステラス製薬株式会社 改良型ヒト化抗ヒトα９インテグリン抗体
JP5339748B2 (ja) * 2008-03-11 2013-11-13 国立大学法人北海道大学 ヒトオステオポンチンの活性化を阻害する物質をスクリーニングする方法
US8614296B2 (en) * 2008-04-24 2013-12-24 Gene Techno Science Co., Ltd. Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
EP2495319B1 (en) 2009-10-21 2018-12-05 Hiroshima University Integrin alpha8beta1-specific monoclonal antibody
WO2012050646A2 (en) 2010-06-29 2012-04-19 The Trustees Of The University Of Pennsylvania Biomimetic chemical sensors using nanoelectronic readout of olfactory receptors
WO2013033359A1 (en) * 2011-08-31 2013-03-07 The Trustees Of The University Of Pennsylvania Carbon nanotube biosensors and related methods
EP2921502A4 (en) 2012-10-19 2016-09-28 Evec Inc AGAINST TOXIN FROM CLOSTRIDIUM DIFFICILE OR ANTIGENBINDING FRAGMENT SPECIFIC HUMAN ANTIBODY
US9649375B2 (en) 2013-03-14 2017-05-16 The Administrators Of The Tulane Educational Fund Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith
CN104250302B (zh) 2013-06-26 2017-11-14 上海君实生物医药科技股份有限公司 抗pd‑1抗体及其应用
TW201623329A (zh) * 2014-06-30 2016-07-01 亞佛瑞司股份有限公司 針對骨調素截斷變異體的疫苗及單株抗體暨其用途
US11415546B2 (en) 2014-09-05 2022-08-16 The Trustees Of The University Of Pennsylvania Volatile organic compound-based diagnostic systems and methods
WO2018009440A1 (en) 2016-07-06 2018-01-11 Dana Automotive Systems Group, Llc Axle and propeller shaft quick-connect joint attachment assembly
KR20180000875U (ko) 2016-09-21 2018-03-29 전은희 조명 모듈
CN112480250B (zh) * 2020-12-23 2022-03-15 上海交通大学 一种抗人骨桥蛋白的抗体及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
KR100337069B1 (ko) 1993-03-11 2002-10-11 사이단호진가가쿠오요비겟세이리요호오겐큐쇼 항-hiv모노클로날항체
DE4425115A1 (de) * 1994-07-15 1996-01-18 Boehringer Mannheim Gmbh Verfahren zur Modifizierung der Stabilität von Antikörpern
WO1998002462A1 (en) * 1996-07-16 1998-01-22 Morphosys Gesellschaft Für Proteinoptimierung Mbh Immunoglobulin superfamily domains and fragments with increased solubility
BR0208809A (pt) * 2001-04-05 2004-03-09 Immuno Biolog Labiratories Co Anticorpo de anti-osteopontina, agente terapêutico para tratar doenças autoimunes, método e kit de detecção de anormalidades inflamatórias e uso do anticorpo
JP4355571B2 (ja) 2001-07-19 2009-11-04 ウニベルジテート チューリッヒ ヒト可変ドメインの改変
RU2305111C2 (ru) 2001-09-25 2007-08-27 Джуридикэл Фаундейшн Дзе Чемо-Серо-Терапьютик Рисерч Инститьют Рекомбинантное антитело против остеопонтина и его применение
WO2003105782A2 (en) * 2002-06-17 2003-12-24 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Specificity grafting of a murine antibody onto a human framework
JPWO2004103403A1 (ja) * 2003-05-23 2006-07-20 株式会社 免疫生物研究所 免疫担当細胞活性化阻害剤およびその用途
EP1805220A1 (en) 2004-10-13 2007-07-11 Genentech, Inc. Method for treating tumors using anti-osteopontin antibodies
JP2006152892A (ja) 2004-11-29 2006-06-15 Anest Iwata Corp 気体吸排機械
EP2395026B1 (en) * 2005-02-08 2018-01-24 The Chemo-Sero-Therapeutic Research Institute Method for improving antibody

Also Published As

Publication number Publication date
TW200813087A (en) 2008-03-16
CA2653661A1 (en) 2007-12-06
US20090053212A1 (en) 2009-02-26
CN101495632B (zh) 2011-08-03
JP4064441B2 (ja) 2008-03-19
EP2025749A1 (en) 2009-02-18
US7807161B2 (en) 2010-10-05
RU2008152769A (ru) 2010-07-20
BRPI0711229A2 (pt) 2013-01-08
IL195503A0 (en) 2011-08-01
RU2429016C2 (ru) 2011-09-20
AU2007268591A1 (en) 2007-12-06
JP2008005836A (ja) 2008-01-17
WO2007139164A1 (ja) 2007-12-06
CN101495632A (zh) 2009-07-29
ES2384350T3 (es) 2012-07-04
ATE553130T1 (de) 2012-04-15
MX2008015309A (es) 2009-03-02
EP2025749B8 (en) 2012-05-23
EP2025749B1 (en) 2012-04-11
KR20090024748A (ko) 2009-03-09
EP2025749A4 (en) 2009-12-16
ZA200810863B (en) 2010-08-25

Similar Documents

Publication Publication Date Title
ATE553130T1 (de) Humanisierter anti-human-osteopontin-antikörper
ATE535545T1 (de) Chimäre und humanisierte monoklonale antikörper gegen interleukin-13
WO2005092926A3 (en) Reducing the risk of human and anti-human antibodies through v gene manipulation
NO20190202A1 (no) Anvendelse av anti-CGRP antagonist antistoff
RS53760B1 (en) HUMAN ANTIBODIES RELATING TO MESOTELINE AND THEIR USES
ATE512986T1 (de) Antikörper gegen clostridium difficile-toxine und ihre verwendung
RU2018119686A (ru) Антитела и фрагменты антител для сайт-специфического конъюгирования
LTPA2016026I1 (lt) Anti-il-17 antikūnai
NZ595464A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
DK3332808T3 (da) Humaniserede L243-antistoffer
DK2019840T3 (da) Antagonist anti-human CD40 monoklonalt antistof.
ATE520716T1 (de) Humanisierter anti-cd4-antikörper mit immunsuppressiven eigenschaften
EA200702008A1 (ru) Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека
RS53984B1 (en) IP-10 ANTIBODIES AND THEIR USES
DE602006017373D1 (de) Madcam-antikörper
RS54271B1 (en) HUMAN MONOCLONIC ANTIBODIES FOR LIGAND PROGRAMMED DEATH 1 (PD-L1)
RS54624B1 (en) MONOCLONIC ANTIBODIES AGAINST GLIPICAN-3
BRPI0811526A2 (pt) uso de um anticorpo monoclonal, quimérico, humanizado ou humano que liga o il-5r, anticorpo anti-il-5r isolado, e, epítopo isolado de il-5r alfa
RS53793B1 (en) HUMANIZED ANTIBODIES AGAINST BETA AMYLOID
BRPI0821211A2 (pt) Anticorpo anti-humano cd34 humanizado, o método de preparação e usos do mesmo.
DK2171060T3 (da) Superagonistisk anti-CD28-antistof
DK1519748T3 (da) Mikropartikler med CD28-specifikke monoklonale antistoffer
WO2004108766A3 (en) Anti-hgf-r antibodies and their use
MX2009005103A (es) Conjugado anti-idiotipo y su uso como un estandar en un inmunoensayo.
DK1907854T3 (da) Monoklonale antistoffer, hybridomcellelinjer, fremgangsmåder og kits til detektion af phytase

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application